Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 642 entries
Sorted by: Best Match Show Resources per page
Conceptual aspects of the quantification of the extent of biological diversity

Stem workforce diversity

May RM.
GSID: 4DqR8eoEdOMJ
RM May - … Transactions of the Royal Society of London …, 1994 - royalsocietypublishing.org

This paper begins by asking to what extent numbers of species are an adequate measure of biological diversity, either locally or globally; both for evolutionary understanding and for practical applications, biodiversity may often be better quantified at lower or...

Cite
May, R. M. (1994). Conceptual aspects of the quantification of the extent of biological diversity. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 345(1311), 13-20.
May, Robert M. "Conceptual aspects of the quantification of the extent of biological diversity." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 345.1311 (1994): 13-20.
Copy Download .nbib Format: MLA
Mentorship for scholarliness: opportunities and dilemmas.

Nursing outlook

May KM, Meleis AI, Winstead-Fry P.
PMID: 6916196
Nurs Outlook. 1982 Jan;30(1):22-8.

No abstract available.

Cite
May KM, Meleis AI, Winstead-Fry P. Mentorship for scholarliness: opportunities and dilemmas. Nurs Outlook. 1982;30(1):22-8
May, K. M., Meleis, A. I., & Winstead-Fry, P. (1982). Mentorship for scholarliness: opportunities and dilemmas. Nursing outlook, 30(1), 22-8.
May, K M, et al. "Mentorship for scholarliness: opportunities and dilemmas." Nursing outlook vol. 30,1 (1982): 22-8.
May KM, Meleis AI, Winstead-Fry P. Mentorship for scholarliness: opportunities and dilemmas. Nurs Outlook. 1982 Jan;30(1):22-8. PMID: 6916196.
Copy Download .nbib Format: NLM
Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart.

Lancet (London, England)

Nabeebaccus A, Hafstad A, Eykyn T, Yin X, Brewer A, Zhang M, Mayr M, Shah A.
PMID: 26312895
Lancet. 2015 Feb 26;385:S73. doi: 10.1016/S0140-6736(15)60388-9.

BACKGROUND: The mechanisms that determine whether the heart adapts to overload stress, or fails, are poorly understood. NADPH oxidase (NOX) proteins produce reactive oxygen species (ROS) involved in redox signalling, and our recent studies have found that an increase...

Cite
Nabeebaccus A, Hafstad A, Eykyn T, et al. Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart. Lancet. 2015;385:S73doi: 10.1016/S0140-6736(15)60388-9.
Nabeebaccus, A., Hafstad, A., Eykyn, T., Yin, X., Brewer, A., Zhang, M., Mayr, M., & Shah, A. (2015). Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart. Lancet (London, England), 385S73. https://doi.org/10.1016/S0140-6736(15)60388-9
Nabeebaccus, Adam, et al. "Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart." Lancet (London, England) vol. 385 (2015): S73. doi: https://doi.org/10.1016/S0140-6736(15)60388-9
Nabeebaccus A, Hafstad A, Eykyn T, Yin X, Brewer A, Zhang M, Mayr M, Shah A. Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart. Lancet. 2015 Feb 26;385:S73. doi: 10.1016/S0140-6736(15)60388-9. PMID: 26312895.
Copy Download .nbib Format: NLM
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open forum infectious diseases

Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R.
PMID: 25734170
Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec.

BACKGROUND: Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs.METHODS: A multicenter, randomized, blinded...

Cite
Mulligan MJ, Bernstein DI, Frey S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014;1(3):ofu102doi: 10.1093/ofid/ofu102.
Mulligan, M. J., Bernstein, D. I., Frey, S., Winokur, P., Rouphael, N., Dickey, M., Edupuganti, S., Spearman, P., Anderson, E., Graham, I., Noah, D. L., Mangal, B., Kim, S., Hill, H., Whitaker, J., Emery, W., Beck, A., Stephens, K., Hartwell, B., Ogilvie, M., Rimann, N., Osinski, E., Destefano, E., Gajadhar, T., Strudwick, A., Pierce, K., Lai, L., Yue, L., Wang, D., Ying, C., Cline, A., Foltz, T., Wagner, N., Dull, G., Pacatte, T., Taggart, B., Johnson, V., Haller, L., Looney, C., Li, S., May, M., Myers, B., May, R., Parker, L., Cochran, N., Bowen, D., Bell, M., Scoggins, J., Burns, A., Stablein, C., Wolff, M., Jolles, B., Leung, B., Lambert, L., Shorer, S., Buchanan, W., Murray, S., Chang, S., & Gorman, R. (2014). Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open forum infectious diseases, 1(3), ofu102. https://doi.org/10.1093/ofid/ofu102
Mulligan, Mark J, et al. "Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial." Open forum infectious diseases vol. 1,3 (2014): ofu102. doi: https://doi.org/10.1093/ofid/ofu102
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec. PMID: 25734170; PMCID: PMC4324215.
Copy Download .nbib Format: NLM
Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis.

Frontiers in microbiology

Madu UL, Ogundeji AO, Mochochoko BM, Pohl CH, Albertyn J, Swart CW, Allwood JW, Southam AD, Dunn WB, May RC, Sebolai OM.
PMID: 26696972
Front Microbiol. 2015 Dec 09;6:1351. doi: 10.3389/fmicb.2015.01351. eCollection 2015.

We previously reported on a 3-hydroxy fatty acid that is secreted via cryptococcal capsular protuberances - possibly to promote pathogenesis and survival. Thus, we investigated the role of this molecule in mediating the fate of Cryptococcus (C.) neoformans and...

Cite
Madu UL, Ogundeji AO, Mochochoko BM, et al. Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis. Front Microbiol. 2015;6:1351doi: 10.3389/fmicb.2015.01351.
Madu, U. L., Ogundeji, A. O., Mochochoko, B. M., Pohl, C. H., Albertyn, J., Swart, C. W., Allwood, J. W., Southam, A. D., Dunn, W. B., May, R. C., & Sebolai, O. M. (2015). Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis. Frontiers in microbiology, 61351. https://doi.org/10.3389/fmicb.2015.01351
Madu, Uju L, et al. "Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis." Frontiers in microbiology vol. 6 (2015): 1351. doi: https://doi.org/10.3389/fmicb.2015.01351
Madu UL, Ogundeji AO, Mochochoko BM, Pohl CH, Albertyn J, Swart CW, Allwood JW, Southam AD, Dunn WB, May RC, Sebolai OM. Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis. Front Microbiol. 2015 Dec 09;6:1351. doi: 10.3389/fmicb.2015.01351. eCollection 2015. PMID: 26696972; PMCID: PMC4673343.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Riccio R, Aziz A, Rink M, Peyromaure M, Shariat S, May M, Xylinas E.
PMID: 26544307
Prog Urol. 2015 Nov;25(13):770. doi: 10.1016/j.purol.2015.08.111.

No abstract available.

Cite
Riccio R, Aziz A, Rink M, et al. Optimisation de la transcription des résultats de la cystectomie totale : vers la définition d'un Trifecta et d'un Pentafecta. [Not Available]. Prog Urol. 2015;25(13):770doi: 10.1016/j.purol.2015.08.111.
Riccio, R., Aziz, A., Rink, M., Peyromaure, M., Shariat, S., May, M., & Xylinas, E. (2015). Optimisation de la transcription des résultats de la cystectomie totale : vers la définition d'un Trifecta et d'un Pentafecta. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 770. https://doi.org/10.1016/j.purol.2015.08.111
Riccio, R, et al. "Optimisation de la transcription des résultats de la cystectomie totale : vers la définition d'un Trifecta et d'un Pentafecta." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 770. doi: https://doi.org/10.1016/j.purol.2015.08.111
Riccio R, Aziz A, Rink M, Peyromaure M, Shariat S, May M, Xylinas E. Optimisation de la transcription des résultats de la cystectomie totale : vers la définition d'un Trifecta et d'un Pentafecta. [Not Available]. Prog Urol. 2015 Nov;25(13):770. doi: 10.1016/j.purol.2015.08.111. French. PMID: 26544307.
Copy Download .nbib Format: NLM
The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia.

Stem cells translational medicine

Zullo JA, Nadel EP, Rabadi MM, Baskind MJ, Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS, Ratliff BB.
PMID: 25947337
Stem Cells Transl Med. 2015 Jul;4(7):852-61. doi: 10.5966/sctm.2014-0111. Epub 2015 May 06.

UNLABELLED: : We previously reported the delivery of endothelial progenitor cells (EPCs) embedded in hyaluronic acid-based (HA)-hydrogels protects renal function during acute kidney injury (AKI) and promotes angiogenesis. We attempted to further ameliorate renal dysfunction by coembedding EPCs with...

Cite
Zullo JA, Nadel EP, Rabadi MM, et al. The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem Cells Transl Med. 2015;4(7):852-61doi: 10.5966/sctm.2014-0111.
Zullo, J. A., Nadel, E. P., Rabadi, M. M., Baskind, M. J., Rajdev, M. A., Demaree, C. M., Vasko, R., Chugh, S. S., Lamba, R., Goligorsky, M. S., & Ratliff, B. B. (2015). The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem cells translational medicine, 4(7), 852-61. https://doi.org/10.5966/sctm.2014-0111
Zullo, Joseph A, et al. "The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia." Stem cells translational medicine vol. 4,7 (2015): 852-61. doi: https://doi.org/10.5966/sctm.2014-0111
Zullo JA, Nadel EP, Rabadi MM, Baskind MJ, Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS, Ratliff BB. The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem Cells Transl Med. 2015 Jul;4(7):852-61. doi: 10.5966/sctm.2014-0111. Epub 2015 May 06. PMID: 25947337; PMCID: PMC4479616.
Copy Download .nbib Format: NLM
A dietary phytochemical alters caste-associated gene expression in honey bees.

Science advances

Mao W, Schuler MA, Berenbaum MR.
PMID: 26601244
Sci Adv. 2015 Aug 28;1(7):e1500795. doi: 10.1126/sciadv.1500795. eCollection 2015 Aug.

In the eusocial honey bee Apis mellifera, with reproductive queens and sterile workers, a female larva's developmental fate depends on its diet; nurse bees feed queen-destined larvae exclusively royal jelly, a glandular secretion, but worker-destined larvae receive royal jelly...

Cite
Mao W, Schuler MA, Berenbaum MR. A dietary phytochemical alters caste-associated gene expression in honey bees. Sci Adv. 2015;1(7):e1500795doi: 10.1126/sciadv.1500795.
Mao, W., Schuler, M. A., & Berenbaum, M. R. (2015). A dietary phytochemical alters caste-associated gene expression in honey bees. Science advances, 1(7), e1500795. https://doi.org/10.1126/sciadv.1500795
Mao, Wenfu, et al. "A dietary phytochemical alters caste-associated gene expression in honey bees." Science advances vol. 1,7 (2015): e1500795. doi: https://doi.org/10.1126/sciadv.1500795
Mao W, Schuler MA, Berenbaum MR. A dietary phytochemical alters caste-associated gene expression in honey bees. Sci Adv. 2015 Aug 28;1(7):e1500795. doi: 10.1126/sciadv.1500795. eCollection 2015 Aug. PMID: 26601244; PMCID: PMC4643792.
Copy Download .nbib Format: NLM
Analysis of Patient Outcomes Using the MyoKinesthetic System for the Treatment of Low Back Pain: A Case Series.

Journal of chiropractic medicine

Brody K, Nasypany AM, Baker RT, May JM.
PMID: 28559751
J Chiropr Med. 2017 Jun;16(2):111-121. doi: 10.1016/j.jcm.2017.01.002. Epub 2017 Mar 18.

OBJECTIVE: The purpose of this case series was to test the feasibility of using the MyoKinesthetic (MYK) System as a treatment-based classification system and intervention for a sample of patients with low back pain.METHODS: This within-subject intervention was completed...

Cite
Brody K, Nasypany AM, Baker RT, et al. Analysis of Patient Outcomes Using the MyoKinesthetic System for the Treatment of Low Back Pain: A Case Series. J Chiropr Med. 2017;16(2):111-121doi: 10.1016/j.jcm.2017.01.002.
Brody, K., Nasypany, A. M., Baker, R. T., & May, J. M. (2017). Analysis of Patient Outcomes Using the MyoKinesthetic System for the Treatment of Low Back Pain: A Case Series. Journal of chiropractic medicine, 16(2), 111-121. https://doi.org/10.1016/j.jcm.2017.01.002
Brody, Kari, et al. "Analysis of Patient Outcomes Using the MyoKinesthetic System for the Treatment of Low Back Pain: A Case Series." Journal of chiropractic medicine vol. 16,2 (2017): 111-121. doi: https://doi.org/10.1016/j.jcm.2017.01.002
Brody K, Nasypany AM, Baker RT, May JM. Analysis of Patient Outcomes Using the MyoKinesthetic System for the Treatment of Low Back Pain: A Case Series. J Chiropr Med. 2017 Jun;16(2):111-121. doi: 10.1016/j.jcm.2017.01.002. Epub 2017 Mar 18. PMID: 28559751; PMCID: PMC5440689.
Copy Download .nbib Format: NLM
Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy.

ACG case reports journal

DiGiovanni EL, Champeaux AL, Arroyo MR, Richter JE.
PMID: 26958557
ACG Case Rep J. 2016 Jan 20;3(2):95-7. doi: 10.14309/crj.2016.11. eCollection 2016 Jan.

We present a case of proton pump inhibitor-responsive eosinophilic esophagitis (PPI-REE) in a patient with severe dysphagia and markedly elevated baseline esophageal eosinophilia that was previously deemed unresponsive to PPI. Upon reintroduction to PPI therapy with monthly endoscopy and...

Cite
DiGiovanni EL, Champeaux AL, Arroyo MR, et al. Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy. ACG Case Rep J. 2016;3(2):95-7doi: 10.14309/crj.2016.11.
DiGiovanni, E. L., Champeaux, A. L., Arroyo, M. R., & Richter, J. E. (2016). Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy. ACG case reports journal, 3(2), 95-7. https://doi.org/10.14309/crj.2016.11
DiGiovanni, Ernest L, et al. "Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy." ACG case reports journal vol. 3,2 (2016): 95-7. doi: https://doi.org/10.14309/crj.2016.11
DiGiovanni EL, Champeaux AL, Arroyo MR, Richter JE. Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy. ACG Case Rep J. 2016 Jan 20;3(2):95-7. doi: 10.14309/crj.2016.11. eCollection 2016 Jan. PMID: 26958557; PMCID: PMC4748193.
Copy Download .nbib Format: NLM
Erratum to: Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging.

European radiology

Huber A, Landau J, Ebner L, Bütikofer Y, Leidolt L, Brela B, May M, Heverhagen J, Christe A.
PMID: 27048537
Eur Radiol. 2016 Oct;26(10):3653. doi: 10.1007/s00330-016-4325-3.

No abstract available.

Cite
Huber A, Landau J, Ebner L, et al. Erratum to: Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging. Eur Radiol. 2016;26(10):3653doi: 10.1007/s00330-016-4325-3.
Huber, A., Landau, J., Ebner, L., Bütikofer, Y., Leidolt, L., Brela, B., May, M., Heverhagen, J., & Christe, A. (2016). Erratum to: Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging. European radiology, 26(10), 3653. https://doi.org/10.1007/s00330-016-4325-3
Huber, Adrian, et al. "Erratum to: Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging." European radiology vol. 26,10 (2016): 3653. doi: https://doi.org/10.1007/s00330-016-4325-3
Huber A, Landau J, Ebner L, Bütikofer Y, Leidolt L, Brela B, May M, Heverhagen J, Christe A. Erratum to: Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging. Eur Radiol. 2016 Oct;26(10):3653. doi: 10.1007/s00330-016-4325-3. PMID: 27048537.
Copy Download .nbib Format: NLM
Top tips for reflection.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

May R.
PMID: 27380682
Nurs Stand. 2016 Jul 06;30(45):27. doi: 10.7748/ns.30.45.27.s26.

I made a commitment, months ago, to go through revalidation ahead of schedule. It seemed a good idea when sitting by the fire, catching up with emails and Twitter on a dark winter's evening.

Cite
May R. Top tips for reflection. Nurs Stand. 2016;30(45):27doi: 10.7748/ns.30.45.27.s26.
May, R. (2016). Top tips for reflection. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 30(45), 27. https://doi.org/10.7748/ns.30.45.27.s26
May, Ruth. "Top tips for reflection." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 30,45 (2016): 27. doi: https://doi.org/10.7748/ns.30.45.27.s26
May R. Top tips for reflection. Nurs Stand. 2016 Jul 06;30(45):27. doi: 10.7748/ns.30.45.27.s26. PMID: 27380682.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 642 entries